ORIZURU THERAPEUTICS INC.: Regenerative Medicine and Drug Discovery using iPS technology

Top 10 Biotech Startups in Apac - 2022

Currently, biotechnology startups place a greater emphasis on automation and computer-aided drug development. The most recent industry trends include the incorporation of AI, the development of personalized medicine, an increase in digital diagnosis, and a greater emphasis on immune cell functions.

The global Biotechnology services market was estimated at US$ 129.15 billion in 2021 and has grown at a compound annual growth rate (CAGR) of 15.6% to US$ 149.32. These trends have contributed to the potential for a sizable market for companies to invest further in the biotechnology startup sector.

This issue of Startup City features the ‘Top 5 Biotech startups in Japan - 2022’ which highlights some of the most important developments in the Japanese biotechnology space, as well as how biotechnology startups are operating in the current business environment and how they improve productivity and profitability.

The edition also includes a list of the ‘Top 10 Biotech Startups in APAC,’ highlighting the trends and developments in biotechnology startups throughout the Asia-Pacific region.

Furthermore, it includes the ‘Top 5 Biotech Startups in Singapore - 2022’ and ‘Top 5 Biotech Startups in South Korea - 2022’ which go into greater detail about the characteristics, trends, and developments of biotechnology startups in the respective regions.

It includes companies such as Orizuru Therapeutics, which was founded in 2021 as collaboration between Kyoto University and Takeda Pharmaceutical Company to research and commercialize iPS cell-based medicines. It is primarily concerned with cell regeneration therapy, regenerative medicine products derived from cell transplantation, and medication development.

The magazine also highlights the opinions of Michael Krel, Partner, Industrial Biotech Strategy, Sofinnova Partners, and Dr. Dan Liu, Partner in Venture and Growth Capital, CDH Investments. They respectively discuss the biotechnology industry’s evolution, challenges, and future, as well as how the industry is shaping up in China’s currently volatile business environment.

Write to us about how Biotechnology has assisted in the functioning of your organizations!

    Top Biotech Startups in Apac

    Established in Malaysia, Auxi Therapeutics provides a variety of T-cell-based immunotherapy for cancer treatment. Its mission is to contribute to society by helping patients’ access affordable treatments in South East Asia and the world ... read full profile
    iN Therapeutics is a spin-off biotech, from a leading local pharmaceutical company, Daewoong Pharmaceuticals, with a new drug discovery platform for an ion channel, Nav1.7 non-opioid analgesic, and treatments for hearing loss and neurological diseases ... read full profile
    PVP Labs has always been on a mission to develop innovative drugs with the potential to make a world of difference in the healthcare space, pain management in particular. Adhering to this goal, the biotech-savvy team at PVP Labs has been conducting extensive research on peptide-based pain management since 2010. ... read full profile
    VCCT
    VC Cell Therapy, founded two years ago, is focused on offering practical application of regenerative therapy to treat retinal degeneration. The company leverages iPS cell-derived pigment epithelial (iPS-RPE) to effectively treat age-related macular degeneration, retinitis pigmentosa, and other retinal orphan diseases
    Anticancer Bioscience
    Anticancer Bioscience is a global precision oncology company that uses synthetic lethal methods to create tailored cancer medicines. The business focuses on cancers with MYC overexpression, which affects more than 50% of tumours and is associated with aggressive and poorly differentiated malignancies
    bitBiome
    bitBiome sequences the genomic information of all microorganisms on Earth at the highest resolution. In order to develop a cutting-edge data-driven bioproduction platform in cooperation with industrial partners, the company has built a massive. Microbial Genome Database that outperforms others in both quality and quantity
    Heartseed
    Since its founding in 2015, Heartseed has been working toward the clinical application of cardiac regenerative medicine with the goal of opening the door to heart disease treatment with regenerative medicine
    Immunophage Biotech
    Immunophage Biotech is a clinical-stage biopharmaceutical company. The company focuses on understanding the pathogenic mechanisms of diseases, investigates new targets in-depth, and creates novel medications for serious conditions such malignant tumours, autoimmune diseases, and neurodegenerative diseases
    KYinno
    Kyinnois committed to providing oncology drug discovery services and developing tailored products. KYinno specialises in humanised antibody design and development, hybridoma antibody synthesis, in vitro compound IC50 measurement, in vivo therapeutic efficacy evaluation, and engineered cell line building
    MDimune
    MDimune takes part in the creation of ground-breaking anticancer medications. The ultimate objective is to offer a cuttingedge platform technology that can achieve target-specific medication delivery, which will alter the paradigm of human therapies